文献速递疝与腹壁外科围术期管理与 ERAS

Poly-4-hydroxybutyrate(Phasix™)补片在复杂腹壁修复中的覆盖式应用

Poly-4-hydroxybutyrate (Phasix™) mesh onlay in complex abdominal wall repair.
PubMed 文献 · Surg Endosc · 2020-05-08

本研究前瞻性随访105例接受腹壁组件分离联合P4HB补片覆盖式加强的复杂腹壁修复患者,中位随访36个月,疝复发率17%,补片感染率低且无患者需完全移除补片,即使在高合并症及污染术野患者中。

要点

  • P4HB补片覆盖式加强在复杂腹壁修复中疝复发率17%,中位随访36个月。
  • 在高合并症及污染术野患者中补片感染率低,无患者需完全移除补片。
  • 5%患者发生局部浅表感染,2.8%因伤口不愈再手术,6%发生血清肿。

核心结论

  • 在高合并症患者中,组件分离联合P4HB补片覆盖式加强的复杂腹壁修复,疝复发、血清肿等常见并发症发生率相对较低。
  • 补片感染率低,即使置于污染或感染术野,也无患者需完全移除补片。

研究设计与样本

  • 前瞻性随访2014年6月至2017年5月期间接受复杂腹壁修复的患者。
  • 仅纳入接受组件分离、筋膜缘一期修复后以P4HB补片覆盖式加强的患者,共105例(男52例,女53例;平均年龄59.2岁,范围22-84)。

主要发现

  • 平均BMI为29.1(范围16-48),52%患者有既往疝修补尝试史,71%患者ASA分级3级或以上。
  • 30%病例修复时术野非清洁(CDC 2级或以上)。
  • 5例(5%)发生局部浅表感染并接受抗生素治疗,3例(2.8%)因伤口不愈需再手术,6例(6%)发生血清肿。

临床怎么用

  • 对于复杂腹壁修复,可考虑组件分离联合P4HB补片覆盖式加强,尤其在污染或感染术野中补片感染风险较低且无需完全移除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Poly-4-hydroxybutyric acid (P4HB, Phasix™) is a biosynthetic polymer that degrades by hydrolysis that can be woven into a mesh for use in soft tissue reinforcement. Herein, we describe our initial experience performing complex abdominal wall repair (CAWR) utilizing component separation and P4HB mesh as onlay reinforcement. METHODS: All patients undergoing CAWR between June 2014 and May 2017 were followed prospectively for postoperative outcomes. Only those patients who underwent components separation with primary repair of the fascial edges followed by onlay of P4HB mesh were included in this study. RESULTS: 105 patients (52 male, 53 female; mean age 59.2 years, range 22-84) met inclusion criteria. Mean BMI was 29.1 (range 16-48); 52% patients had prior attempted hernia repair, most with multiple medical comorbidities (71% of patients with ASA 3 or greater). 30% of cases were not clean at the time of repair (CDC class 2 or greater). Median follow-up was 36 months (range 9-63). Eighteen patients (17%) developed a hernia recurrence ranging from 2 to 36 months postoperatively. Five (5%) patients developed a localized superficial infection treated with antibiotics, three (2.8%) required re-operation for non-healing wounds, and six (6%) patients developed seroma. CONCLUSIONS: These data demonstrate a relatively low rate of hernia recurrence, seroma, and other common complications of CAWR in a highly morbid patient population. Importantly, the rate of mesh infection was low and no patients required complete mesh removal, even when placed into a contaminated or infected surgical field.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Levy AS, Bernstein JL, Premaratne ID, et al. Poly-4-hydroxybutyrate (Phasix™) mesh onlay in complex abdominal wall repair. Surg Endosc. 2020. PMID: 32385706. doi:10.1007/s00464-020-07601-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。